ReviewJPRAS open2025
Adipose-derived stem cells in fat grafting for facial paralysis: A review of their therapeutic modality.
Review in JPRAS open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Advancing body contouring: A comprehensive review of intramuscular fat grafting techniques, outcomes, and safety considerations.JPRAS open · 2026Review
- Advancing fat graft survival: from adipose-derived stem cell mechanisms to next-generation regenerative strategies.Frontiers in cell and developmental biology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Facial paralysis, characterized by the complete loss of voluntary muscle control in the face, significantly affects individuals' daily lives. Recently, stem cell therapy has gained attention as a potential treatment for various medical conditions due to its capacity for self-renewal and differentiation into specialized cell types. Adipose-derived stem cells (ADSCs), obtained from the stromal-vascular fraction, consist of mesenchymal stem cells (MSCs), smooth muscle cells, endothelial cells, pericytes, lymphocytes, and tissue macrophages. Both differentiated and undifferentiated MSCs support axonal regeneration, enhance motor function, and promote growth factor release. ADSCs have been shown to improve regenerative outcomes, including better axonal development, increased myelinated fiber count, greater myelin thickness, and enhanced target reinnervation. These cells can differentiate into various lineages, particularly Schwann-like cells that facilitate axon regeneration. Additionally, ADSCs play a role in healing peripheral nerves by releasing neurotrophic and angiogenic factors. While the results are not as effective as nerve autografts, ADSCs offer an alternative option for reconstructing facial nerve paralysis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.